// App-Quantinova.ai

S2129 2016 AHA : Cost-Effectiveness Analysis of Dexrazoxane in Preventing Long-Term Cardiac Dysfunction in Paediatric Patients With Haematological Malignancies

Researchers

Presenter

  • Ying Wang

Principal Investigators

  • Faraz Pathan

  • Thomas H Marwick

Medical Centers

  • Menzies Institute of Medical Research, Hobart, Australia

  • Baker IDI Heart & Diabetes Institute, Melbourne, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute lymphoblastic leukemia

  • Hematological malignancies

  • Congestive heart failure

  • Cardiotoxicity

Biomarkers

  • N/A

Drug/Treatment

  • ADR-529

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved